ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,747Medicare Part D Prescriptions Filled, Including Refills

Rank: 11 out of 356

$487K Total Retail Price of All Prescriptions

Rank: 60 out of 356

567 Patients Receiving at Least One Drug in Part D
66%Patients 65 Years and Older
57% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

11% of this provider’s 567 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 6,577 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 4%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $94 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
PREDNISONE 1,033 638 1 10
THEOPHYLLINE ANHYDROUS 978 603 10 2 65
ALBUTEROL SULFATE 543 390 3 131
FUROSEMIDE 497 353 4 3
POTASSIUM CHLORIDE 470 259 5 12
PROAIR HFA 373 196 6 53
SPIRIVA 257 145 7 33
VENTOLIN HFA 250 142 8 81
HYDROCODONE-ACETAMINOPHEN 233 98 S3 9 1
LEVOFLOXACIN 199 126 10 107
SINGULAIR 195 109 11 80
ADVAIR DISKUS 189 107 12 52
GABAPENTIN 148 78 13 5
OMEPRAZOLE 140 109 14 7
SIMVASTATIN 128 70 15 4
MONTELUKAST SODIUM 127 67 16 142
AMOX TR-POTASSIUM CLAVULANATE 122 80 17 128
METFORMIN HCL 116 70 18 13
KLOR-CON M20 115 97 19 109
FLUTICASONE PROPIONATE 114 79 20 36
LISINOPRIL 113 67 21 6
DIGOXIN 112 85 22 42
ZOLPIDEM TARTRATE 109 71 23 24
LEVOTHYROXINE SODIUM 105 69 24 8
DILTIAZEM ER 102 54 25 148
FLOVENT HFA 101 63 26 287
METOPROLOL TARTRATE 99 75 27 9
DILTIAZEM 24HR CD 84 42 28 119
HYDRALAZINE HCL 83 40 29 31
RANITIDINE HCL 83 62 29 41
ISOSORBIDE MONONITRATE ER 81 57 31 45
AMLODIPINE BESYLATE 76 63 32 2
HYDROCHLOROTHIAZIDE 76 63 32 19
ACETAMINOPHEN-CODEINE 69 53 S3 34 187
SERTRALINE HCL 69 46 34 49
TRAMADOL HCL 67 57 36 26
GLYBURIDE 65 27 R 37 92
SYMBICORT 61 12 38 147
AZITHROMYCIN 61 41 38 88
WARFARIN SODIUM 60 49 40 14
CLOPIDOGREL 56 36 41 15
AMITRIPTYLINE HCL 56 40 R 41 79
DOXYCYCLINE HYCLATE 56 31 41 120
TAMSULOSIN HCL 55 55 44 39
DOXEPIN HCL 55 38 44 251
COMBIVENT 53 21 46 156
CLONIDINE HCL 50 11 47 17
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.